Report Detail

Pharma & Healthcare Global Nucleic Acid Based Gene Therapy Market Growth (Status and Outlook) 2022-2028

  • RnM4404457
  • |
  • 21 March, 2022
  • |
  • Global
  • |
  • 100 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of Nucleic Acid Based Gene Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Nucleic Acid Based Gene Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nucleic Acid Based Gene Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Nucleic Acid Based Gene Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Nucleic Acid Based Gene Therapy market, reaching US$ million by the year 2028. As for the Europe Nucleic Acid Based Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Nucleic Acid Based Gene Therapy players cover Wave Life Sciences, Imugene, Sarepta Therapeutics, and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Based Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals and Clinics
Academic and Research Institutes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Nucleic Acid Based Gene Therapy Market Size 2017-2028
    • 2.1.2 Nucleic Acid Based Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Nucleic Acid Based Gene Therapy Segment by Type
    • 2.2.1 Anti-Sence and Anti-Gene
    • 2.2.2 Short Inhibitory Sequences
    • 2.2.3 Gene Transfer Therapy
    • 2.2.4 Nucleoside Analogs
    • 2.2.5 Ribozymes
    • 2.2.6 Aptamers
    • 2.2.7 Others
  • 2.3 Nucleic Acid Based Gene Therapy Market Size by Type
    • 2.3.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2022)
  • 2.4 Nucleic Acid Based Gene Therapy Segment by Application
    • 2.4.1 Hospitals and Clinics
    • 2.4.2 Academic and Research Institutes
    • 2.4.3 Others
  • 2.5 Nucleic Acid Based Gene Therapy Market Size by Application
    • 2.5.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2022)

3 Nucleic Acid Based Gene Therapy Market Size by Player

  • 3.1 Nucleic Acid Based Gene Therapy Market Size Market Share by Players
    • 3.1.1 Global Nucleic Acid Based Gene Therapy Revenue by Players (2020-2022)
    • 3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2020-2022)
  • 3.2 Global Nucleic Acid Based Gene Therapy Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Nucleic Acid Based Gene Therapy by Regions

  • 4.1 Nucleic Acid Based Gene Therapy Market Size by Regions (2017-2022)
  • 4.2 Americas Nucleic Acid Based Gene Therapy Market Size Growth (2017-2022)
  • 4.3 APAC Nucleic Acid Based Gene Therapy Market Size Growth (2017-2022)
  • 4.4 Europe Nucleic Acid Based Gene Therapy Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
  • 5.2 Americas Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
  • 5.3 Americas Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Nucleic Acid Based Gene Therapy Market Size by Region (2017-2022)
  • 6.2 APAC Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
  • 6.3 APAC Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Nucleic Acid Based Gene Therapy by Country (2017-2022)
  • 7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
  • 7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Nucleic Acid Based Gene Therapy by Region (2017-2022)
  • 8.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Nucleic Acid Based Gene Therapy Market Forecast

  • 10.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2023-2028)
    • 10.1.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2023-2028)
    • 10.1.2 Americas Nucleic Acid Based Gene Therapy Forecast
    • 10.1.3 APAC Nucleic Acid Based Gene Therapy Forecast
    • 10.1.4 Europe Nucleic Acid Based Gene Therapy Forecast
    • 10.1.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast
  • 10.2 Americas Nucleic Acid Based Gene Therapy Forecast by Country (2023-2028)
    • 10.2.1 United States Nucleic Acid Based Gene Therapy Market Forecast
    • 10.2.2 Canada Nucleic Acid Based Gene Therapy Market Forecast
    • 10.2.3 Mexico Nucleic Acid Based Gene Therapy Market Forecast
    • 10.2.4 Brazil Nucleic Acid Based Gene Therapy Market Forecast
  • 10.3 APAC Nucleic Acid Based Gene Therapy Forecast by Region (2023-2028)
    • 10.3.1 China Nucleic Acid Based Gene Therapy Market Forecast
    • 10.3.2 Japan Nucleic Acid Based Gene Therapy Market Forecast
    • 10.3.3 Korea Nucleic Acid Based Gene Therapy Market Forecast
    • 10.3.4 Southeast Asia Nucleic Acid Based Gene Therapy Market Forecast
    • 10.3.5 India Nucleic Acid Based Gene Therapy Market Forecast
    • 10.3.6 Australia Nucleic Acid Based Gene Therapy Market Forecast
  • 10.4 Europe Nucleic Acid Based Gene Therapy Forecast by Country (2023-2028)
    • 10.4.1 Germany Nucleic Acid Based Gene Therapy Market Forecast
    • 10.4.2 France Nucleic Acid Based Gene Therapy Market Forecast
    • 10.4.3 UK Nucleic Acid Based Gene Therapy Market Forecast
    • 10.4.4 Italy Nucleic Acid Based Gene Therapy Market Forecast
    • 10.4.5 Russia Nucleic Acid Based Gene Therapy Market Forecast
  • 10.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast by Region (2023-2028)
    • 10.5.1 Egypt Nucleic Acid Based Gene Therapy Market Forecast
    • 10.5.2 South Africa Nucleic Acid Based Gene Therapy Market Forecast
    • 10.5.3 Israel Nucleic Acid Based Gene Therapy Market Forecast
    • 10.5.4 Turkey Nucleic Acid Based Gene Therapy Market Forecast
    • 10.5.5 GCC Countries Nucleic Acid Based Gene Therapy Market Forecast
  • 10.6 Global Nucleic Acid Based Gene Therapy Forecast by Type (2023-2028)
  • 10.7 Global Nucleic Acid Based Gene Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Wave Life Sciences
    • 11.1.1 Wave Life Sciences Company Information
    • 11.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offered
    • 11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Wave Life Sciences Main Business Overview
    • 11.1.5 Wave Life Sciences Latest Developments
  • 11.2 Imugene
    • 11.2.1 Imugene Company Information
    • 11.2.2 Imugene Nucleic Acid Based Gene Therapy Product Offered
    • 11.2.3 Imugene Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Imugene Main Business Overview
    • 11.2.5 Imugene Latest Developments
  • 11.3 Sarepta Therapeutics
    • 11.3.1 Sarepta Therapeutics Company Information
    • 11.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offered
    • 11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Sarepta Therapeutics Main Business Overview
    • 11.3.5 Sarepta Therapeutics Latest Developments
  • 11.4 Alnylam Pharmaceuticals
    • 11.4.1 Alnylam Pharmaceuticals Company Information
    • 11.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
    • 11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Alnylam Pharmaceuticals Main Business Overview
    • 11.4.5 Alnylam Pharmaceuticals Latest Developments
  • 11.5 Ionis Pharmaceuticals
    • 11.5.1 Ionis Pharmaceuticals Company Information
    • 11.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
    • 11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Ionis Pharmaceuticals Main Business Overview
    • 11.5.5 Ionis Pharmaceuticals Latest Developments
  • 11.6 Moderna
    • 11.6.1 Moderna Company Information
    • 11.6.2 Moderna Nucleic Acid Based Gene Therapy Product Offered
    • 11.6.3 Moderna Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Moderna Main Business Overview
    • 11.6.5 Moderna Latest Developments
  • 11.7 BioNTech
    • 11.7.1 BioNTech Company Information
    • 11.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Offered
    • 11.7.3 BioNTech Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 BioNTech Main Business Overview
    • 11.7.5 BioNTech Latest Developments
  • 11.8 Nutcracker Therapeutics
    • 11.8.1 Nutcracker Therapeutics Company Information
    • 11.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offered
    • 11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Nutcracker Therapeutics Main Business Overview
    • 11.8.5 Nutcracker Therapeutics Latest Developments
  • 11.9 Deep Genomics
    • 11.9.1 Deep Genomics Company Information
    • 11.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Offered
    • 11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Deep Genomics Main Business Overview
    • 11.9.5 Deep Genomics Latest Developments
  • 11.10 Sirnaomics
    • 11.10.1 Sirnaomics Company Information
    • 11.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Offered
    • 11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Sirnaomics Main Business Overview
    • 11.10.5 Sirnaomics Latest Developments
  • 11.11 Laronde
    • 11.11.1 Laronde Company Information
    • 11.11.2 Laronde Nucleic Acid Based Gene Therapy Product Offered
    • 11.11.3 Laronde Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Laronde Main Business Overview
    • 11.11.5 Laronde Latest Developments
  • 11.12 Abogen Biosciences
    • 11.12.1 Abogen Biosciences Company Information
    • 11.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offered
    • 11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Abogen Biosciences Main Business Overview
    • 11.12.5 Abogen Biosciences Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Nucleic Acid Based Gene Therapy. Industry analysis & Market Report on Nucleic Acid Based Gene Therapy is a syndicated market report, published as Global Nucleic Acid Based Gene Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nucleic Acid Based Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,898.72
5,797.44
3,381.84
6,763.68
553,721.40
1,107,442.80
305,134.20
610,268.40
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report